Newsroom
Stay up to date on the latest Legend news and information from Legend Biotech.
Stay up to date on the latest Legend news and information from Legend Biotech.
SOMERSET, N.J.—May 6, 2022—Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the upcoming investor conferences: Event: Bank of America Securities 2022 Healthcare ConferencePresentation Date & Time: Wednesday, May 11, 2022 at 5:20pm PT / 8:20pm ETLocation: Las […]
May 06, 2022
SOMERSET, N.J.— (BUSINESS WIRE) —April 21, 2022— Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced the achievement of a $50 million milestone under its collaboration agreement with Janssen Biotech, Inc. (Janssen) for ciltacabtagene autoleucel (cilta-cel), now marketed in the United […]
Apr 21, 2022
SOMERSET, N.J.— (BUSINESS WIRE) —April 1, 2022— Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced the appointment of Guowei Fang, Ph.D., as Senior Vice President, Global Head of Research and Early Development. Dr. Guowei Fang is an accomplished scientist and […]
Apr 01, 2022
Ciltacabtagene autoleucel, if approved by the European Commission (EC), will be Legend Biotech’s first EC-approved product SOMERSET, N.J.— (BUSINESS WIRE) —March 25, 2022— Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced that the Committee for Medicinal Products for Human Use […]
Mar 25, 2022
SOMERSET, N.J. — March 23, 2022 — Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, was named Newcomer of the Year at the tenth annual Foreign Investment Trophy ceremony hosted by Flanders Investment & Trade (FIT). Flanders Investment and Trade is a […]
Mar 23, 2022
Thank you for your interest in learning more about Legend Biotech.
media@legendbiotech.com
You are going to a website that Legend Biotech does not operate and to which Legend Biotech's privacy policy does not apply. Legend Biotech is not responsible for the content, format, maintenance or policies of the website you are about to visit and does not endorse or monitor any content on such website.